Pneumonia News and Research

Latest Pneumonia News and Research

COVID-19 pandemic highlights the risk of using systemic corticosteroids

Healthcare workers in tropical and sub-tropical settings where strongyloidiasis is prevalent or caring for patients who have travelled to such areas, need to maintain a high level of awareness about the use of corticosteroids, including when this class of anti-inflammatories is given to patients suspected of infection with SARS-CoV-2.

17 Dec 2020

Researchers use bacterial strains to measure host gene expression in mouse model

The bacteria Streptococcus pneumoniae colonizes the nasopharynx and can cause pneumonia. Then, it can spread from the lungs to the bloodstream and cause organ damage.

16 Dec 2020

Research reveals two phases of infection in patients with severe COVID-19 pneumonia

What does SARS-CoV-2, the virus that causes COVID-19, do once it enters a person's airways, and how does infection in lung cells affect patients' immune responses?

16 Dec 2020

Researchers focus on preventing infections caused by carbapenemase-producing bacteria

In 2017, the World Health Organization published a list of pathogens for which new drugs are urgently needed.

16 Dec 2020

Azithromycin trial fails to provide evidence of benefit in COVID-19

Early on in the COVID-19 pandemic, azithromycin was regarded as being a potentially highly effective drug against the virus that causes it, SARS-CoV-2.

16 Dec 2020

Chemical found in cigarettes could increase severity of COVID-19, new study finds

A new study has found that high levels of the chemical cadmium, is associated with an increased risk of death in patients with influenza or pneumonia.

16 Dec 2020

RedHill Biopharma announces promising preliminary results from opaganib study

TEL AVIV, Israel and RALEIGH, NC, December 15, 2020, RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced promising preliminary results from a preclinical study with opaganib.

15 Dec 2020

Study provides valuable interaction about animal host and pathogen during pneumococcal infections

Researchers at the University of Maryland School of Medicine published one of the most comprehensive analyses of how genes get expressed during infection (known as a transcriptome). The analyses include three different strains of the bacteria Streptococcus pneumoniae, which causes pneumonia, meningitis, and middle-ear infections.

15 Dec 2020

Study: First week and a half after leaving hospital may be dangerous for COVID-19 patients

In the first months after their COVID-19 hospital stay, patients face a high risk of ongoing health problems, trips back to the hospital, and death, a growing number of studies has shown.

14 Dec 2020

Epitope “megapools” could help determine role T cell immunity plays in COVID-19

Researchers in the United States and Australia have conducted a comprehensive analysis of the epitope recognition patterns associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in humans.

14 Dec 2020

Lung ultrasounds can predict outcomes in COVID-19 patients

For some, COVID-19 can result in severe pneumonia or even death, while others remain purely asymptomatic. A diagnostic tool could help physicians predict if a patient with COVID-19 will worsen.

11 Dec 2020

Pulmonary rehabilitation may promote recovery in severe COVID-19

A new study compares rehabilitation outcomes between COVID-19 patients and those with ordinary pneumonia, to evaluate the effectiveness of interventions.

11 Dec 2020

New collaborative study to address key questions about COVID-19

A new nationwide study of more than 50,000 individuals is underway to determine factors that predict disease severity and long-term health impacts of COVID-19.

11 Dec 2020

COVID-19 infection may also affect the central nervous system, cause neurological disorders

COVID-19 is known primarily as a respiratory disease, with symptoms that include cough, shortness of breath, and, in severe cases, acute respiratory distress syndrome and pneumonia

10 Dec 2020

SARS-CoV-2 spike protein mediates acute lung pathology in mice

A study shows that the viral spike protein is adequate by itself to induce macrophage activation in pulmonary tissue and induce acute inflammation.

10 Dec 2020

WHO highlights leading causes of mortality and morbidity worldwide from 2000 to 2019

Noncommunicable diseases now make up 7 of the world's top 10 causes of death, according to WHO's 2019 Global Health Estimates, published today.

9 Dec 2020

Scientists provide insight on how lung bacteria protect against invading pathogens

New insight on how bacteria in the lungs protect against invading pathogens has been published today in the open-access eLife journal.

8 Dec 2020

Lipid storm in severe COVID-19 linked to high COX/LOX pathway activity

A potentially valuable new study discusses the role of lipids in the hyper-inflammatory phenomena that take place within the lungs of patients with severe or critical COVID-19. Involving a large variety of specialized lipids with biological activity, this process includes the generation and release of pro and anti-inflammatory lipids.

8 Dec 2020

Study confirms most common complications associated with COVID-19

A large study of patients in the United States who contracted coronavirus disease 2019 (COVID-19) confirms many complications of the disease, according to new research in CMAJ (Canadian Medical Association Journal).

8 Dec 2020

Lung, kidney and cardiovascular issues are confirmed as complications of COVID-19

A new study published this month confirms the many complications of COVID-19 including cardiovascular, kidney, and lung complications.

8 Dec 2020

Pneumonia News and Research

Latest Pneumonia News and Research

COVID-19 pandemic highlights the risk of using systemic corticosteroids

Researchers use bacterial strains to measure host gene expression in mouse model

Research reveals two phases of infection in patients with severe COVID-19 pneumonia

Researchers focus on preventing infections caused by carbapenemase-producing bacteria

Azithromycin trial fails to provide evidence of benefit in COVID-19

Chemical found in cigarettes could increase severity of COVID-19, new study finds

RedHill Biopharma announces promising preliminary results from opaganib study

Study provides valuable interaction about animal host and pathogen during pneumococcal infections

Study: First week and a half after leaving hospital may be dangerous for COVID-19 patients

Epitope “megapools” could help determine role T cell immunity plays in COVID-19

Lung ultrasounds can predict outcomes in COVID-19 patients

Pulmonary rehabilitation may promote recovery in severe COVID-19

New collaborative study to address key questions about COVID-19

COVID-19 infection may also affect the central nervous system, cause neurological disorders

SARS-CoV-2 spike protein mediates acute lung pathology in mice

WHO highlights leading causes of mortality and morbidity worldwide from 2000 to 2019

Scientists provide insight on how lung bacteria protect against invading pathogens

Lipid storm in severe COVID-19 linked to high COX/LOX pathway activity

Study confirms most common complications associated with COVID-19

Lung, kidney and cardiovascular issues are confirmed as complications of COVID-19

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Pneumonia News and Research

Latest Pneumonia News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in